# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 2


A statement describing the types of investigational medicinal product in respect of which the authorisation is required, including their pharmaceutical forms and whether any of them is an MM investigational medicinal product or a POC investigational medicinal product.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/6/paragraph/2 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-6/paragraph-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.